Oriola Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,821

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 2

Oriola General Information

Description

Distributor of pharmaceutical products. The company operates as a distributor, wholesaler and service provider whose products and marketing service palette encompasses pharmaceuticals, consumer health and beauty products.

Contact Information

Website
www.oriola.ru
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Specialty Retail
Primary Office
  • 2 Dzerzhinskoe Shosse
  • Kotelniki
  • Moscow, 140055
  • Russia
+7 8 (000) 000-00-00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oriola Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oriola‘s full profile, request access.

Request a free trial

Oriola Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oriola Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oriola‘s full profile, request access.

Request a free trial

Oriola Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Doktor.se 27-May-2020 00000 0000 000.00 Clinics/Outpatient Services
Doktor.se 04-May-2018 Early Stage VC 000.00 Clinics/Outpatient Services
To view Oriola’s complete investments history, request access »